Consistent with the previous studies, the present research also confirmed that inhibition of TAGLN2/PI3K/Akt pathway potentiated the suppressive effect of Sal A on TMZ resistance in glioma cells. The gene discussed is TAGLN2; the disease is central nervous system cancer.